SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     



J Nucl Med. 2008; 49 (Supplement 1):261P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chang, C.-C.
Right arrow Articles by Chen, Y.-W.
PubMed
Right arrow Articles by Chang, C.-C.
Right arrow Articles by Chen, Y.-W.

General Clinical Specialties: General Practice-Oncology

General Practice-Oncology Posters

18F-FDG PET/CT in patients with cancer of an unknown primary

Chin-Chuan Chang1, Po-Nien Hou1, Chia-Yang Lin1, Chuan-Shaio Lee1, Yu-Wen Chen1 and Yu-Wen Chen2

1 Department of Nuclear Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; 2 Faculty of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

1119

Objectives: This retrospective study was undertaken to address the result of positron emission tomography/computed tomography (PET/CT) with 18F-FDG to determine the primary tumor origin of carcinomas with unknown primary site.

Methods: Between February 2006 and October 2007, twenty-four patients (10 men, 14 women; mean age, 55.5 years) with pathologically proven metastatic cancer of unknown primary site were referred to our PET/CT center. For all patients, extensive imaging was unsuccessful in localizing the primary site. Each patient underwent a PET/CT scan, carried out according to a standard procedure (6 hours of fasting, intravenous injection of 10mCi of 18F-FDG and whole body image acquisition with a dedicated PET/CT scanner).

Results: Twenty-three patients were eligible for analysis except a woman (#16) who had underlying breast cancer. In 9 patients (39.1%), FDG PET/CT showed a primary tumor site which was confirmed by follow-up or surgery. In another 6 patients (26.1%), the primary tumor site was suggested by FDG PET/CT but not confirmed by clinical outcome. No primary tumor was found on PET/CT image in the other 8 patients (34.8%).

Conclusions: In our study, FDG PET/CT allowed the identification of primary tumor site in about forty percent of patients with unknown primary tumor. The encouraging results, if validated by larger patient population, support the use of PET/CT in patients with carcinoma of unknown primary origin.





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chang, C.-C.
Right arrow Articles by Chen, Y.-W.
PubMed
Right arrow Articles by Chang, C.-C.
Right arrow Articles by Chen, Y.-W.